Login

Financial Snapshot

Revenue
TTM
$44.33M
Gross Margin
TTM
76.9%
Net Income
TTM
$16.05M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
130.88%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.838M
Cash
2026 Q1
P/E
TTM
8.358
Free Cash Flow
TTM
$3.987M

Stock Price

Loading...
Market Cap: $134.14 Million

About SANUWAVE Health Inc

SANUWAVE Health Inc (OTC: SNWV) is a medical device company that develops and commercializes devices subject to FDA regulation. Revenue is transactional, generated through the sale and use of medical devices, with third-party reimbursement anticipated as a component of the commercial model as described in the FY2025 10-K filed March 26, 2026. The company operates in the United States healthcare market and is subject to federal and state anti-kickback statutes, FDA oversight, and healthcare fraud and abuse laws applicable to medical device manufacturers. SNWV does not pay cash dividends and has stated its intent to retain any future earnings to finance operations. As of the FY2025 filing, Morgan Frank serves as Chief Executive Officer. The company's capital structure includes debt with associated issuance costs and discounts, derivative liabilities, and stock-based compensation, indicating a leveraged balance sheet with no dividend distributions.

Revenue model
Transactional revenue from sale of medical devices; third-party reimbursement from payors anticipated as part of the commercial model per the FY2025 10-K.
Products and services
FDA-regulated medical devices; the filing references a PACE product line with inventory written off related to PACE disposal during FY2025. Patent assets were also sold during FY2025.
Customers and end markets
Hospitals, physicians, and other healthcare purchasers in the United States. End market is U.S. healthcare, with reimbursement dependent on third-party payors including federal healthcare programs.
Value-chain role
Medical device manufacturer subject to FDA regulation; sells directly to healthcare providers and is subject to federal and state anti-kickback and false claims laws.
Geographic exposure
United States, based on regulatory framework described in the FY2025 10-K.

Source: SEC 10-K, filed 2026-03-26

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Streamex Corp Microbot Medical Inc Sonendo, Inc. electroCore, Inc. INVACARE HOLDINGS Corp Nemaura Medical Inc. Precision Optics Corporation Inc Vivani Medical Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support